In 1951 Churg and Strauss described 13 cases of allergic angiitis and granulomatosis characterised by hypereosinophilia and systemic vasculitis occurrin in patients with asthma and allergic rhinitis. Pulmonary infiltrates remained a hallmark of the acute vasculitic phase of the disease, occurring in 72% of patients with the Churg-Strauss syndrome in a review of published work by Lanham et al. 2 Patients with fulminating pulmonary involvement can deteriorate while receiving a moderate dose of corticosteroids. 3 We report a case of the ChurgStrauss syndrome occurring in a Chinese patient presenting with systemic necrotising vasculitis and acute pulmonary exacerbation. The patient rapidly developed hypoxaemic respiratory failure despite oral corticosteroid and responded dramatically after 'pulses' of intravenous cyclophosphamide.
Case report
A 51 year old Chinese housewife who had had allergic rhinitis for 10 years and asthmatic attacks for the past year was admitted with a two month history of increased attacks of breathlessness, showers of haemorrhagic spots over both legs, multiple small joint pain, and weakness of the extremities. She was afebrile but had malaise and weight loss of 2 kg. There was no family history of asthma or other allergic diseases. Physical examination on admission showed bilateral foot drop, small muscle wasting of Despite prednisone 60 mg a day for nine days our patient deteriorated rapidly with severe hypoxaemia and was on the verge of assisted ventilation. Under these circumstances most would advocate early aggressive immunosuppressive treatment, which now centres around the use of cyclophosphamide.7-9
The serum IgE concentration of our patient was markedly raised during the acute vasculitic phase and returned to normal during disease remission. Peripheral eosinophilia also climbed to a peak value during the fulminating pulmonary vasculitic phase. These findings are similar to reports from Hammersmith. 
